These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 970875)

  • 1. [Antithrombin III during coagulation in vitro].
    Aiach M; Andreux JP; Fiessinger JN; Beuvin J; Leclerc M
    Ann Pharm Fr; 1976; 34(1-2):43-50. PubMed ID: 970875
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in antithrombin III during treatment with heparin].
    Aiach M; Beuvin J; Michaud A; Fiessinger JN
    Nouv Presse Med; 1978 Jan; 7(2):120. PubMed ID: 652506
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood coagulation activities of the vascular intima. 10. Intimal antithrombin of the human aorta].
    Ota G; Tsubokawa Y; Masaoka N
    Igaku To Seibutsugaku; 1968 Sep; 77(3):101-5. PubMed ID: 5750581
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood coagulation activities on the vascular intima. 9. Intimal antithrombin and atherosclerosis in man].
    Ota G; Tsubokawa Y
    Igaku To Seibutsugaku; 1968 Sep; 77(3):95-9. PubMed ID: 5750583
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemistry of heparin and low molecular weight heparin.
    Nielsen JI; Ostergaard P
    Acta Chir Scand Suppl; 1988; 543():52-6. PubMed ID: 2847458
    [No Abstract]   [Full Text] [Related]  

  • 7. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-thormbin III and heparin clotting times in thrombosis and atherosclerosis.
    O'Brien JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):116-23. PubMed ID: 4454034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antithrombin activity of blood in experimental extrahepatic cholestasis].
    Burnazian RA; Kiianov VI; Petrishchev NN
    Zh Eksp Klin Med; 1976; 16(2):22-8. PubMed ID: 973498
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibitors of the serine-proteases of coagulation with special reference to antithrombin III and heparin cofactor II].
    Fontcuberta J
    Sangre (Barc); 1985; 30(4-C):787-91. PubMed ID: 3841417
    [No Abstract]   [Full Text] [Related]  

  • 11. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest.
    Sas G; Pepper DS; Cash JD
    Thromb Diath Haemorrh; 1975 Jun; 33(3):564-72. PubMed ID: 1154312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of antithrombin III activity in hypercoagulability].
    von Kaulla E; von Kaulla KN
    Dtsch Med Wochenschr; 1977 Apr; 102(13):496. PubMed ID: 844430
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antithrombin 3. Its physicochemical properties and pathophysiological significance (author's transl)].
    Aoki N; Igarashi M
    Nihon Ketsueki Gakkai Zasshi; 1973 Aug; 36(4):472-6. PubMed ID: 4799440
    [No Abstract]   [Full Text] [Related]  

  • 14. [The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].
    Kase F; Pospísil J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):337-49. PubMed ID: 6194066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic low molecular weight inhibitors of thrombin.
    Geratz JD
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):455-70. PubMed ID: 4121339
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanism of inhibition of blood coagulation (author's transl)].
    Kurachi K
    Tanpakushitsu Kakusan Koso; 1980 Dec; 25(13):1031-40. PubMed ID: 7025099
    [No Abstract]   [Full Text] [Related]  

  • 17. Alteration of plasma antithrombin III levels in ischemic heart disease.
    Yue RH; Gertler MM; Starr T; Koutrouby R
    Thromb Haemost; 1976 Jun; 35(3):598-606. PubMed ID: 989967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypercoagulability in atrial fibrillation and its relationship with risk factors for systemic embolism].
    Pérez LA; Corbalán R; Acevedo M; Pereira J; Braun S; Tapia J; Kramer A; Lira MT; Huete I; Sepúlveda G; Springmüller D
    Rev Med Chil; 2002 Oct; 130(10):1087-94. PubMed ID: 12491825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of anti-factor Xa and antithrombin activities of low molecular weight heparins.
    Lane DA; Ryan K
    J Lab Clin Med; 1990 Aug; 116(2):269-70. PubMed ID: 2394942
    [No Abstract]   [Full Text] [Related]  

  • 20. On the complex formation of antithrombin 3 with thrombin. Gelfiltration studies on human plasma and serum.
    Binder B
    Thromb Diath Haemorrh; 1973 Nov; 30(2):280-3. PubMed ID: 4589772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.